Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- ASCO AT A GLANCE: Genetic Research A Focus Of Cancer Meeting
Jun 02, 2008 05:24 PM
- Pfizer, Avant Report Positive Results In Brain Cancer Vaccine
Jun 02, 2008 11:30 AM
- NASDAQ Technical Picture - Hanging Man Confirmed
May 20, 2008 12:13 AM
- NASDAQ Technical Picture - Hanging Man to End Bullish Week
May 19, 2008 01:56 AM
- UPDATE: Positive Lilly Cancer Drug Trial Among ASCO Releases
May 15, 2008 10:46 PM
- Global Investing Roundups
Apr 19, 2008 04:20 PM
- CORRECT: =UPDATE: Pfizer In Brain-Cancer Vaccine Deal With Avant
Apr 16, 2008 07:56 PM
- CORRECT: =UPDATE: Pfizer In Brain-Cancer Vaccine Deal With Avant
Apr 16, 2008 07:56 PM
- CORRECT: UPDATE: Pfizer In Brain-Cancer Vaccine Deal With Avant 2-
Apr 16, 2008 07:56 PM
- UPDATE: Pfizer In Brain-Cancer Vaccine Deal With Avant
Apr 16, 2008 06:39 PM
- AVANT Immunotherapeutics Announces Name Change to Celldex Therapeutics
Sep 29, 2008 08:14 AM
- AVANT CEO To Present at the UBS 2008 Global Life Sciences Conference September 23
Sep 18, 2008 04:01 PM
- AVANT CEO to Present at the 28th Annual Canaccord Adams Global Growth Conference
Aug 08, 2008 04:17 PM
- CORRECTING and REPLACING AVANT Reports Second Quarter and Six Month Financial Results
Aug 06, 2008 08:46 AM
- AVANT Reports Second Quarter and Six Month Financial Results
Aug 06, 2008 08:06 AM
- AVANT to Report Second Quarter 2008 Financial Results on August 6, 2008
Aug 04, 2008 01:57 PM
- AVANT Announces Vaccine Adjuvant Licenses with 3M
Jun 11, 2008 08:02 AM
- AVANT CEO to Present at the Needham & Company Biotechnology & Medical Technology Conference
Jun 04, 2008 11:03 AM
- NIH Initiates Phase 1 Safety Study of AVANT's Oral Combined Enterotoxigenic E. coli-Cholera Vaccine
Jun 04, 2008 08:12 AM
- Market Pulse Breaking News Alert for Tuesday, June 3, 2008: NCEN – NACEL Energy Achieves Objectives With 640 MW Wind Power in Development, Sets New 1000 MW Target and Prepares for Rapid Expansion!
Jun 03, 2008 08:30 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
AVAN
|
Compare to S&P
|
| YTD |
93.76 %
|
138.58 %
|
| 4 Weeks |
-15.91 %
|
-7.51 %
|
| 12 Weeks |
-17.28 %
|
-11.19 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 8.22 %
|
|
EPS Growth in Last Year: 20.27 %
|
|
Sales Growth in Last Quarter: 1,234.69 %
|
|
Sales Growth in Last Quarter: 94.45 %
|
|
|
